Status:

UNKNOWN

Prevention of Primary Postpartum Haemorrhage

Lead Sponsor:

Islamabad Medical and Dental College

Conditions:

Primary

Post Partum Hemorrhage

Eligibility:

FEMALE

18-40 years

Phase:

PHASE2

Brief Summary

Postpartum hemorrhage, is one of the most deadly complication of pregnancy worldwide and major cause of maternal mortality especially in third world countries .1 PPH affects about 5% of all women givi...

Detailed Description

Data will be collected from all the patients full filling inclusion criteria on especially designed Performa after informed consent of patient, demographic data will be collected on that preform Patie...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • 1\. All LSCS including emergency and elective 2. Full term pregnancy \>37 week
  • Exclusion Criteria:
  • 1\. All vaginal deliveries 2. Patients with bleeding or clotting disorders 3. Maternal cardiac, renal, hepatic diseases 4. Morbidly adherent placentas 5. Preterm deliveries

Exclusion

    Key Trial Info

    Start Date :

    February 3 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 30 2021

    Estimated Enrollment :

    180 Patients enrolled

    Trial Details

    Trial ID

    NCT04724187

    Start Date

    February 3 2021

    End Date

    August 30 2021

    Last Update

    February 25 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Islamabad medical and Dental College

    Islamabad, Federal, Pakistan, 44000